Lebhar-Friedman sheds four titles

Share this article:

B2B media firm Lebhar-Friedman sold the journals division of Dowden Health Media to Quadrant HealthCom in a move it said was designed to decrease reliance on advertising-based businesses.

The transaction, brokered by media bankers Desilva + Phillips, closed in December, and terms were not disclosed.
It gives Quadrant HealthCom four Dowden Professional Publications (DPP) journals—OBG Management, Current Psychiatry, The Journal of Family Practice and Mayo Clinic Proceedings—along with Dowden's events division.

Commenting on the sale, Lebhar-Friedman president Roger Friedman told MM&M that with the dropoff in journal ad pages and numerous blockbusters losing patent protection in the next few years, his company was looking for less exposure to advertising-dependent businesses.

“We wanted to get away from products that were strictly advertising-based, and the professional journals group at Dowden was almost entirely advertising-based,” said Friedman. “We'd rather be in databases, research education—more proprietary products.”

As part of the sale, about 30 Dowden employees will relocate to Quadrant's headquarters in Parsippany, NJ, from Dowden Health Media's office in Montvale, NJ.

All DPP units will continue to be managed by existing personnel, while all Quadrant journals will continue operating in their current mode.

Quadrant president Stephen Stoneburn said in a statement: “We are excited about the opportunity to add leading properties in new therapeutic and audience markets and to expand our already strong presence in the women's healthcare sector.” Quadrant's stable of nine journals includes The Female Patient, Neurology Reviews, Emergency Medicine and Pulmonary Reviews.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"